Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis
Pre-existing hydronephrosis persists after CRT for MIBC in ~ 75% of patients and ~ 20% of patients without pre-existing hydronephrosis develops hydronephrosis after CRT. Around half of these patients receive drainage. These findings may assist in counselling patients with pre-existing hydronephrosis regarding the potential outcomes following CRT.
Authors
- Adriaan D. Bins
- Jorg R. Oddens (ORCID: https://orcid.org/0000-0002-6079-5613)
- Nader el Awadly
- Sven Nadorp
- Maicle R Leter
- Katharina Brück
- Marinka J. Remmelink (ORCID: https://orcid.org/0000-0002-3118-5373)
- Jakko A. Nieuwenhuijzen (ORCID: https://orcid.org/0000-0002-8977-5501)
- Berber Arbeel-Weening
Institutions
- Dutch Cancer Society (NL)
- Flevoziekenhuis (NL)
- Ziekenhuis Amstelland (NL)
- Westfriesgasthuis (NL)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Radiation Oncology
- Published
- 2025-06-21
- DOI
- https://doi.org/10.1186/s13014-025-02678-9
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00